First Header Logo Second Header Logo

Connection

Anthony Atala to Carcinoma, Transitional Cell

This is a "connection" page, showing publications Anthony Atala has written about Carcinoma, Transitional Cell.
Connection Strength

2.874
  1. Atala A. Re: Mouse and Human Urothelial Cancer Organoids: A Tool for Bladder Cancer Research. J Urol. 2019 10; 202(4):664.
    View in: PubMed
    Score: 0.671
  2. Atala A. Re: Epigenetic Silencing of the Dual-Role Signal Mediator, ANGPTL4 in Tumor Tissues and Its Overexpression in the Urothelial Carcinoma Microenvironment. J Urol. 2019 06; 201(6):1057.
    View in: PubMed
    Score: 0.659
  3. Atala A. Re: Mutations in 3'-long terminal repeat of HERV-W family in chromosome 7 upregulate syncytin-1 expression in urothelial cell carcinoma of the bladder through interacting with c-Myb. J Urol. 2015 Mar; 193(3):1061.
    View in: PubMed
    Score: 0.484
  4. Atala A. Re: Dietary sources of N-nitroso compounds and bladder cancer risk: findings from the Los Angeles Bladder Cancer Study. J Urol. 2014 Aug; 192(2):614-5.
    View in: PubMed
    Score: 0.464
  5. Atala A. Re: NMR-based metabolomics study of canine bladder cancer. J Urol. 2013 Aug; 190(2):808.
    View in: PubMed
    Score: 0.432
  6. Stanasel I, Atala A, Hemal A. Robotic assisted ureteral reimplantation: current status. Curr Urol Rep. 2013 Feb; 14(1):32-6.
    View in: PubMed
    Score: 0.106
  7. Doherty SC, McKeown SR, McKelvey-Martin V, Downes CS, Atala A, Yoo JJ, Simpson DA, Kaufmann WK. Cell cycle checkpoint function in bladder cancer. J Natl Cancer Inst. 2003 Dec 17; 95(24):1859-68.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.